scispace - formally typeset
J

Jeffrey S. Tan

Researcher at Eli Lilly and Company

Publications -  11
Citations -  597

Jeffrey S. Tan is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Charge (physics) & Singular value. The author has an hindex of 6, co-authored 11 publications receiving 549 citations. Previous affiliations of Jeffrey S. Tan include Purdue University.

Papers
More filters
Journal ArticleDOI

Capillary Precipitation of a Highly Polymorphic Organic Compound

TL;DR: In this article, the authors describe the process of crystallization of pharmaceutically active compounds from saturated solutions by means of solvent evaporation typically involves a nucleation and growth process.
Journal ArticleDOI

Effect of gastric pH on the pharmacokinetics of a BCS class II compound in dogs: utilization of an artificial stomach and duodenum dissolution model and GastroPlus,™ simulations to predict absorption.

TL;DR: The ASD experiments demonstrated that administration of a buffered acidic solution could improve the potential for absorption by normalizing gastric pH and enabling supersaturation in the duodenum, and GastroPlus™ modeling suggested that direct modulation of gastrics pH could lead to marked changes in bioavailability.
Journal ArticleDOI

Transition-Tempered Metadynamics Is a Promising Tool for Studying the Permeation of Drug-like Molecules through Membranes

TL;DR: Though all of the MetaD simulations agree with one another asymptotically, TTMetaD is able to predict the most accurate and reliable estimate of the potential of mean force for permeation in the early stages of the simulations and is robust to the choice of required additional parameters.
Journal ArticleDOI

Molecular transport through membranes: Accurate permeability coefficients from multidimensional potentials of mean force and local diffusion constants.

TL;DR: This paper presents a multidimensional inhomogeneous solubility-diffusion model to study the permeability of a small molecule drug passing through a POPC (1-palmitoyl-2-oleoyL-sn-glycero-3-phosphocholine) lipid bilayer, and reports a considerably more accurate permeability coefficient.